Hi MB I have appreciated your posts over the last year. They...

Hi MB
I have appreciated your posts over the last year. They have kept me smiling during the down time since the trial failure. Below is my take on the situation facing us shareholders. Feel free to knock the reasoning.

If the SP was to be A$ 1.00 then MC would be A$ 66o M (roughly)
At a P/E of only 15 then earnings would be A$ 44 M
At a margin of 75% ( conservative ?) then sales would be A$ 58.5 M
If app cost US$ 5 per use (A$6.75) then 58.5/6.75 = 8.7 million uses would be required per anum
That would mean only 8.7/360 or 2.4% of all USA cough visits would have to captured by RAP.

To me that does not appear to be unattainable in a short time period. ( say next northern winter).